Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.19 CAD Market Closed
Market Cap: 47.1m CAD

Intrinsic Value

TLT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one TLT stock under the Base Case scenario is 0.01 CAD. Compared to the current market price of 0.19 CAD, Theralase Technologies Inc is Overvalued by 94%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLT Intrinsic Value
0.01 CAD
Overvaluation 94%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Theralase Technologies Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
TLT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TLT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Theralase Technologies Inc
XTSX:TLT
CA
Health Care
Market Cap
47.1m CAD
IPO
Nov 2, 2004
CA
Health Care
Market Cap
47.1m CAD
IPO
Nov 2, 2004
Price
CA$false
EPS
CA$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TLT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Theralase Technologies Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Theralase Technologies Inc

Current Assets 1.6m
Cash & Short-Term Investments 268.8k
Receivables 711.5k
Other Current Assets 603.4k
Non-Current Assets 1.7m
PP&E 605.8k
Other Non-Current Assets 1.1m
Efficiency

Free Cash Flow Analysis
Theralase Technologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Theralase Technologies Inc

Revenue
1m CAD
Cost of Revenue
-479.4k CAD
Gross Profit
554k CAD
Operating Expenses
-4.8m CAD
Operating Income
-4.3m CAD
Other Expenses
32.3k CAD
Net Income
-4.3m CAD
Fundamental Scores

TLT Profitability Score
Profitability Due Diligence

Theralase Technologies Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
23/100
Profitability
Score

Theralase Technologies Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

TLT Solvency Score
Solvency Due Diligence

Theralase Technologies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
60/100
Solvency
Score

Theralase Technologies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

Lowest
Price Target
0.71 CAD
272% Upside
Average
Price Target
0.71 CAD
276% Upside
Highest
Price Target
0.74 CAD
287% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one TLT stock?

The intrinsic value of one TLT stock under the Base Case scenario is 0.01 CAD.

Is TLT stock undervalued or overvalued?

Compared to the current market price of 0.19 CAD, Theralase Technologies Inc is Overvalued by 94%.

Back to Top